Page last updated: 2024-10-24

verapamil and Adult Neuronal Ceroid Lipofuscinosis

verapamil has been researched along with Adult Neuronal Ceroid Lipofuscinosis in 1 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Petcherski, A1
Chandrachud, U1
Butz, ES1
Klein, MC1
Zhao, WN1
Reis, SA1
Haggarty, SJ1
Ruonala, MO1
Cotman, SL1

Other Studies

1 other study available for verapamil and Adult Neuronal Ceroid Lipofuscinosis

ArticleYear
An Autophagy Modifier Screen Identifies Small Molecules Capable of Reducing Autophagosome Accumulation in a Model of CLN3-Mediated Neurodegeneration.
    Cells, 2019, 11-27, Volume: 8, Issue:12

    Topics: Animals; Autophagosomes; Autophagy; Cell Line; Drug Discovery; Fluspirilene; Loss of Function Mutati

2019